PTAB Grants Priority for Eukaryotic CRISPR to Broad in Interference No. 106,115 | McDonnell Boehnen Hulbert & Berghoff LLP
In an 82-page decision, the Patent Trial and Appeal Board granted priority for eukaryotic CRISPR to the Broad Institute, Harvard University, and MIT (collectively, "Broad") as Senior...
Source: jdsupra.com